17,261 trials
Wrinkles
Primary: Severity of the Forehead Wrinkles by the Evaluator at Maximum Contraction and at Rest Using the Forehead Wrinkles Severity Scale (0 to 3) at Each Study Visit and for…
Liver Disease · Liver Transplantation
Primary: Proportion of Participants Who Have Graft Loss or Death — 0.22 Proportion of Participants
Diabetic Foot Ulcer
Primary: Number of Participants Without Adverse Events — 8; 7 participants
Epithelial Ovarian Cancer · Primary Peritoneal Carcinoma
Primary: 6-month Progression-Free Rate — 62.5 percentage of patients
Head Lice
Primary: Percentage of Participants With Treatment Success Following Treatment With Either Ivermectin or Placebo (Vehicle Control) — 95; 53; 83; 49 Percent of Participants
Alzheimer's Disease
Primary: Alzheimer's Disease Assessment Scale, Cognitive Subscale (ADAS-Cog) Score — 18.63; 19.81; 20.66; 20.33 units on a scale — p=0.64
Healthy
Primary: Blood Urea Nitrogen and Creatinine Serum Values — 12.3; 14.7; 14.5; 12.8 mg/dL
Parkinson's Disease
Primary: Change in Facial Entropy Score From Baseline [Off Dopamine Medication] — 5.649; -1.605 units on a scale — p=< 0.001
Esophageal Cancer
Primary: Pathological Complete Response — 26 participants
Lymphoma
Primary: Progression-free Survival — 89 percentage of participants
Hepatitis C · Vasculitis
Primary: Percent of Patients in Remission — 83; 8 percent of participants
Typhoid Fever
Primary: Number of Subjects Reporting Any Post Immunization Reactions — 18; 19; 22; 16 participants
Kidney Neoplasms · Carcinoma, Renal Cell
Primary: Percentage of Participants With Objective Response (OR) — 22.6 Percentage of Participants
Obsessive Compulsive Disorder
Primary: Number of Patients Who Met and Exceeded Response Criteria of Yale-Brown Obsessive-Compulsive Scale — 2 participants
Thyroid Neoplasms
Primary: Percentage of Participants With Objective Response (OR) — 38.3 Percentage of participants